Product Information
BETAMETHASONE DP AUG 0.05% OIN is a generic product labeled by Lupin Pharmaceuticals Inc., priced at $0.5878 per GM under NDC 68180094701. Its NADAC has been published 330 times since Jun 10, 2020.
FDA first approved this application on Dec 18, 2019. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
.5 mg/g
Manufacturer
Lupin Pharmaceuticals Inc.NDC
68180094701
Classification
Generic
Dosage Form
OINTMENT, AUGMENTED
Route
TOPICAL
Effective Date
9/23/2026
Active Ingredients
BETAMETHASONE DIPROPIONATEApproval Type
Generic (ANDA)
FDA Application
ANDA209106FDA Approved
12/18/2019
TE Code
AB
On Market Since
3/19/2020
Pharmacological Classes
Price Statistics
The NADAC for BETAMETHASONE DP AUG 0.05% OIN has been published 330 times since Jun 10, 2020, and over the history we have for it it has declined 65.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.5878 per GM |
|---|---|
| All-time high | $1.8270 (Jul 15, 2020) |
| All-time low | $0.5785 (Aug 19, 2026) |
| 52-week high | $0.8493 |
| 52-week low | $0.5785 |
| Median price | $0.8958 |
| Average price | $1.0234 |
| Largest weekly change | +46.0% (Apr 21, 2021) |
| Weeks tracked | 330 |
| Tracking since | Jun 10, 2020 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 9% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Lupin Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Betamethasone dipropionate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Corticosteroid class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of BETAMETHASONE DP AUG 0.05% OIN?
The current National Average Drug Acquisition Cost (NADAC) for BETAMETHASONE DP AUG 0.05% OIN, manufactured by Lupin Pharmaceuticals Inc., is $0.5878 per GM (NDC 68180094701), effective Sep 30, 2026.
How has the price of BETAMETHASONE DP AUG 0.05% OIN changed over time?
Over the history we have for it, the NADAC for BETAMETHASONE DP AUG 0.05% OIN has declined 65.4%. It has been tracked across 330 weekly CMS publications since Jun 10, 2020.
What are the highest and lowest recorded NADAC prices for BETAMETHASONE DP AUG 0.05% OIN?
Since Jun 10, 2020, the NADAC for BETAMETHASONE DP AUG 0.05% OIN has ranged from a low of $0.5785 (Aug 19, 2026) to a high of $1.8270 (Jul 15, 2020), with a median of $0.8958 per GM.
Are there cheaper alternatives to BETAMETHASONE DP AUG 0.05% OIN?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, BETAMETHASONE DP AUG 0.05% OIN, is $0.5345 per GM — about 9% below BETAMETHASONE DP AUG 0.05% OIN.
Who manufactures BETAMETHASONE DP AUG 0.05% OIN?
BETAMETHASONE DP AUG 0.05% OIN (NDC 68180094701) is labeled by Lupin Pharmaceuticals Inc., and CMS classifies it as a generic product.